A double-blind controlled clinical trial comparing fluvoxamine with imipramine

British Journal of Clinical Pharmacology
J D GuelfiP Pichot

Abstract

1 The effects of fluvoxamine to a maximum of 300 mg daily were compared with those of imipramine to a maximum of 200 mg daily, in 151 patients with primary major depression. 2 Four weeks of treatment with fluvoxamine resulted in 67.2% improvement (+/- s.d. 21.6) on the Hamilton Rating Scale for Depression (26 items). Treatment with imipramine showed 62.1% improvement (+/- s.d. 29.5) on this scale. 3 Fluvoxamine had no untoward effects on the cardiovascular system, while imipramine produced systematic increases in the postural fall in blood pressure. Dry mouth, nausea, daytime somnolence and tremor were seen with fluvoxamine treatment, while imipramine was associated with dry mouth, daytime somnolence, dizziness and tremor. 4 We conclude that fluvoxamine seems to have the same general antidepressant efficacy as imipramine. It was not associated with any safety problems and was generally well tolerated.

References

Aug 1, 1977·British Journal of Pharmacology·V ClaassenP Placheta
May 1, 1972·Archives of General Psychiatry·A CoppenR Noguera
Dec 1, 1967·The British Journal of Psychiatry : the Journal of Mental Science·D M ShawE G Eccleston
Dec 1, 1967·The British Journal of Social and Clinical Psychology·M Hamilton

❮ Previous
Next ❯

Citations

Jan 1, 1990·Progress in Neuro-psychopharmacology & Biological Psychiatry·D RothD V Sheehan
Jun 7, 2011·Pediatric Emergency Care·Kavita M BabuJason B Hack
Mar 13, 2012·Pharmacological Reviews·Stephanie W WattsSusan M Barman
Jan 1, 1989·Psychological Medicine. Monograph Supplement·S J WarringtonM Lader
Sep 7, 2012·International Review of Psychiatry·António Palha, João Marques-Teixeira
Jan 1, 1990·Current Medical Research and Opinion·G GonellaU Ecari
Jan 1, 1985·Current Medical Research and Opinion·U A SiddiquiD K Jesinger
Jan 1, 1983·British Journal of Clinical Pharmacology·J E De WildeJ S Wakelin
Mar 1, 1989·The Australian and New Zealand Journal of Psychiatry·J McGrath
Mar 1, 1991·The Australian and New Zealand Journal of Psychiatry·P D McGorry
Sep 1, 1988·The Australian and New Zealand Journal of Psychiatry·J Lawrence
Feb 18, 2005·International Journal of Geriatric Psychiatry·Maria Stella T GironBengt Winblad
Jan 7, 2015·The Journal of Toxicological Sciences·Yukiko Yamazaki-HashimotoAtsushi Sugiyama
Jul 15, 2005·History of Psychiatry·Jatinder Bains
Apr 3, 2003·Human Psychopharmacology·Shigeru Morishita, Seizaburo Arita
Jul 20, 2007·The Cochrane Database of Systematic Reviews·J R GeddesJ Boynton
Mar 13, 1993·BMJ : British Medical Journal·F SongJ Mason
Feb 1, 1997·The British Journal of Psychiatry : the Journal of Mental Science·M HotopfG Lewis
Mar 20, 2010·The Cochrane Database of Systematic Reviews·Ichiro M OmoriToshi A Furukawa
Mar 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·J G EdwardsG L Pearce
Aug 21, 2021·Frontiers in Cardiovascular Medicine·Anna CalviAderville Cabassi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.